Skip to content

Clinical study on modified Chen's Tang shen fang in treating diabetic nephropathy III complicated with dyslipidemia

Clinical study on modified Chen's Tang shen fang in treating diabetic nephropathy III complicated with dyslipidemia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072919
Enrollment
Unknown
Registered
2023-06-28
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy III with dyslipidemia

Interventions

Experimental group:Modified Chen's Tang Shen Fang, granule, take 2 times a day, 1 pack each time, patients half an hour after breakfast and dinner, once a continuous 3 months
Control Group:The placebo and the granule were given twice a day, one pack at a time, half an hour after breakfast and dinner, for 3 months

Sponsors

Longhua hospital affiliated to Shanghai University of Traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age range, 18-80 years, met the diagnostic criteria for diabetic nephropathy G1-3aA1-3 with dyslipidemia

Exclusion criteria

Exclusion criteria: Other patients with primary or secondary chronic kidney disease, triglyceride and cholesterol levels 4 times higher than normal, pregnant or lactating women, allergic to traditional Chinese medicine; Patients with severe heart, liver, kidney and brain complications, complicated with other serious primary diseases, and psychotic patients.

Design outcomes

Primary

MeasureTime frame
Urinary albumin/creatinine ratio;24h urinary microprotein quantification;24h urine protein quantification;24h urinary a1 microglobulin;24 h urinary ?2 microglobulin;Cystatin C;Total cholesterol;Triglyceride;High-density lipoprotein;Low-density lipoprotein;Fasting blood glucose;Glycated hemoglobin;Glomerular filtration rate (EPI formula);24h urinary albumin excretion rate;

Secondary

MeasureTime frame
Body fat rate;Visceral fat;

Countries

China

Contacts

Public ContactSHENG LINGLI

Longhua hospital affiliated to Shanghai University of Traditional Chinese

star-213@163.com+86 136 0198 2083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026